125 related articles for article (PubMed ID: 9285040)
21. Regulation of CYP4A expression in rat by dehydroepiandrosterone and thyroid hormone.
Webb SJ; Xiao GH; Geoghegan TE; Prough RA
Mol Pharmacol; 1996 Feb; 49(2):276-87. PubMed ID: 8632760
[TBL] [Abstract][Full Text] [Related]
22. Use of primary cultures of adult rat hepatocytes to investigate mechanisms of action of nafenopin, a hepatocarcinogenic peroxisome proliferator.
Bieri F; Bentley P; Waechter F; Stäubli W
Carcinogenesis; 1984 Aug; 5(8):1033-9. PubMed ID: 6146407
[TBL] [Abstract][Full Text] [Related]
23. Comparison of the hepatic effects of nafenopin and WY-14,643 on peroxisome proliferation and cell replication in the rat and Syrian hamster.
Lake BG; Evans JG; Cunninghame ME; Price RJ
Environ Health Perspect; 1993 Dec; 101 Suppl 5(Suppl 5):241-7. PubMed ID: 8013414
[TBL] [Abstract][Full Text] [Related]
24. Hepatocellular DNA synthesis in rats given peroxisome proliferating agents: comparison of WY-14,643 to clofibric acid, nafenopin and LY171883.
Eacho PI; Lanier TL; Brodhecker CA
Carcinogenesis; 1991 Sep; 12(9):1557-61. PubMed ID: 1893515
[TBL] [Abstract][Full Text] [Related]
25. Induction of peroxisomal enzymes in livers of neonatal rats exposed to lactating mothers treated with hypolipidaemic drugs. Role of drug metabolite transfer in milk.
Fahl WE; Lalwani ND; Reddy MK; Reddy JK
Biochem J; 1983 Mar; 210(3):875-83. PubMed ID: 6683505
[TBL] [Abstract][Full Text] [Related]
26. Species and strain sensitivity to the induction of peroxisome proliferation by chloroacetic acids.
DeAngelo AB; Daniel FB; McMillan L; Wernsing P; Savage RE
Toxicol Appl Pharmacol; 1989 Nov; 101(2):285-98. PubMed ID: 2815084
[TBL] [Abstract][Full Text] [Related]
27. Stimulation of DNA synthesis but not of peroxisomal beta-oxidation by nafenopin in primary cultures of marmoset hepatocytes.
Bieri F; Stäubli W; Waechter F; Muakkassah-Kelly S; Bentley P
Cell Biol Int Rep; 1988 Dec; 12(12):1077-87. PubMed ID: 3147145
[TBL] [Abstract][Full Text] [Related]
28. Effects of the hepatocarcinogen nafenopin, a peroxisome proliferator, on the activities of rat liver glutathione-requiring enzymes and catalase in comparison to the action of phenobarbital.
Furukawa K; Numoto S; Furuya K; Furukawa NT; Williams GM
Cancer Res; 1985 Oct; 45(10):5011-9. PubMed ID: 2862989
[TBL] [Abstract][Full Text] [Related]
29. Modulation of plasma and hepatic oxidative status and changes in plasma lipid profile by n-3 (EPA and DHA), n-6 (corn oil) and a 3-thia fatty acid in rats.
Demoz A; Asiedu DK; Lie O; Berge RK
Biochim Biophys Acta; 1994 Apr; 1199(3):238-44. PubMed ID: 8161562
[TBL] [Abstract][Full Text] [Related]
30. In vitro steady-state levels of hydrogen peroxide after exposure of male F344 rats and female B6C3F1 mice to hepatic peroxisome proliferators.
Tomaszewski KE; Agarwal DK; Melnick RL
Carcinogenesis; 1986 Nov; 7(11):1871-6. PubMed ID: 3769136
[TBL] [Abstract][Full Text] [Related]
31. The rodent nongenotoxic hepatocarcinogen and peroxisome proliferator nafenopin inhibits intercellular communication in rat but not guinea-pig hepatocytes, perturbing S-phase but not apoptosis.
Elcock FJ; Chipman JK; Roberts RA
Arch Toxicol; 1998 Jun; 72(7):439-44. PubMed ID: 9708883
[TBL] [Abstract][Full Text] [Related]
32. Suppression of altered hepatic foci development by a high fish oil diet compared with a high corn oil diet in rats.
Lii CK; Ou CC; Liu KL; Liu JY; Lin WL; Chen HW
Nutr Cancer; 2000; 38(1):50-9. PubMed ID: 11341044
[TBL] [Abstract][Full Text] [Related]
33. Butylated hydroxytoluene prevents hepatic damage induced by food oil.
Terrazos-Luch J; Corona-García S; Zentella-de Piña M; Ramirez-González MD; Piña-Garza E
Proc West Pharmacol Soc; 1997; 40():97-9. PubMed ID: 9436224
[TBL] [Abstract][Full Text] [Related]
34. Differential induction of peroxisomal and microsomal fatty-acid-oxidising enzymes by peroxisome proliferators in rat liver and kidney. Characterisation of a renal cytochrome P-450 and implications for peroxisome proliferation.
Sharma RK; Lake BG; Makowski R; Bradshaw T; Earnshaw D; Dale JW; Gibson GG
Eur J Biochem; 1989 Sep; 184(1):69-78. PubMed ID: 2776771
[TBL] [Abstract][Full Text] [Related]
35. Effect of some peroxisome proliferators on transforming growth factor-beta 1 gene expression and insulin-like growth factor II/mannose-6-phosphate receptor gene expression in rat liver.
Rumsby PC; Davies MJ; Price RJ; Lake BG
Carcinogenesis; 1994 Feb; 15(2):419-21. PubMed ID: 8313539
[TBL] [Abstract][Full Text] [Related]
36. The peroxisome proliferator nafenopin does not suppress hepatocyte apoptosis in guinea-pig liver in vivo nor in human hepatocytes in vitro.
Hasmall SC; James NH; Soames AR; Roberts RA
Arch Toxicol; 1998 Dec; 72(12):777-83. PubMed ID: 9950074
[TBL] [Abstract][Full Text] [Related]
37. NTP toxicology and carcinogensis Studies of 2,4-hexadienal (89% trans,trans isomer, CAS No. 142-83-6; 11% cis,trans isomer) (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2003 Oct; (509):1-290. PubMed ID: 14999299
[TBL] [Abstract][Full Text] [Related]
38. Species differences in response to diethylhexylphthalate: suppression of apoptosis, induction of DNA synthesis and peroxisome proliferator activated receptor alpha-mediated gene expression.
Hasmall SC; James NH; Macdonald N; Soames AR; Roberts RA
Arch Toxicol; 2000 Apr; 74(2):85-91. PubMed ID: 10839475
[TBL] [Abstract][Full Text] [Related]
39. Saturable binding sites for the coenzyme A ester of nafenopin, a peroxisome proliferator, in rat liver cytosol.
Morgan C; Bronfman M
Xenobiotica; 1995 Dec; 25(12):1293-300. PubMed ID: 8719905
[TBL] [Abstract][Full Text] [Related]
40. Microsomal lauric acid hydroxylase activities after treatment of rats with three classical cytochrome P450 inducers and peroxisome proliferating compounds.
Dirven HA; van den Broek PH; Peters JG; Noordhoek J; Jongeneelen FJ
Biochem Pharmacol; 1992 Jun; 43(12):2621-9. PubMed ID: 1632818
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
